By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Abbott Laboratories 

Department 383 AP6D
One Hundred Abbott Park Road
Abbott Park  Illinois  60064-3500  U.S.A.
Phone: 847-937-6100 Fax: 847-937-1511


Abbott has facilities in more than 40 countries and markets its products in more than 130 countries. More than 60,000 Abbott employees around the world have devoted their careers to advancing the practice of health care. The largest concentration of Abbott employees is in Lake County, Ill., home to both corporate headquarters at Abbott Park and the company's principal manufacturing location at North Chicago. Still, less than one-third of all Abbott employees are located in Illinois. The majority of our employees are spread across the United States and around the world.

Abbott is building a global portfolio around two key groups - pharmaceuticals and medical products - that form a strategically cohesive business mix.

Our Pharmaceutical Products Group strives to consistently discover, develop and market breakthrough drugs that improve patient health, especially in areas of unmet medical need. The group's primary focus is on translating innovative science into effective medicine and spans several areas, including the Pharmaceutical Products Division, the Nutritionals Division and Abbott International, as well as TAP Pharmaceuticals Inc., Abbott's joint venture with Takeda Chemical Industries, Ltd.

Our Medical Products Group is building leading businesses in hospital based medicines and devices, diagnostic tests and instruments, and nutritionals for adults and children, while identifying ways to promote health through the linkage of drugs, devices, diagnostics and nutritional products.

There's a world of inspiration that you can only get from being a part of the Abbott team. That's because we are made up of people who are passionate about life, health care and the contributions they can make.

For over a century, innovation and success in the areas of pharmaceuticals, nutritionals and diagnostics has enabled Abbott to provide total, integrated solutions for some of the world's most prevalent medical conditions, including: AIDS, cancer and diabetes.

Abbott technologies span the health care spectrum and play a key role in the way people get well and stay healthy. And with $22 billion in sales in more than 130 countries, we don't just see a better world - we're positioned to make it happen.




Founder: Wallace Calvin Abbott

CEO: Miles White

CFO: Brain Yoor


Please click here for Abbott job opportunities.


All Products


Key Statistics

Ownership: Public

Web Site: Abbott
Employees: 54,000
Symbol: ABT


Celera Diagnostics  Long-term strategic alliance to develop, manufacture and market a broad range of in vitro molecular diagnostic products for disease detection, disease progression monitoring and therapy selection.

Genetronics, Inc.  On November 26, 1997, Genetronics announced a supply agreement with Abbott Laboratories allowing Genetronics to purchase the approved anti-cancer drug bleomycin for use with Genetronics MedPulser┬« drug delivery system in treatment of cancer.

Metabolex, Inc. 

Celera Corporation  Broad program to discover, develop and commercialize therapies for the treatment of cancer, including therapeutic antibodies and small molecules.

Rosetta Inpharmatics, Inc.  Investigation on molecular basis of hepatoxicity

Medarex, Inc. 


Company News
FDA OKs Abbott (ABT)' MRI-Compatibility for the Company's Ellipse ICD 9/22/2017 6:35:48 AM
Abbott (ABT) Hosts Conference Call For Third-Quarter Earnings 9/20/2017 9:33:20 AM
Alere (ALR) Announces Intent To Voluntarily Delist Series B Convertible Perpetual Preferred Stock From The NYSE Conditioned Upon The Completion Of Its Acquisition By Abbott (ABT) 9/19/2017 7:50:37 AM
Abbott (ABT) Announces Extension Of Cash Tender Offer For All Outstanding Shares Of Series B Convertible Perpetual Preferred Stock Of Alere (ALR) 9/18/2017 7:33:45 AM
Abbott (ABT) Declares 375th Consecutive Quarterly Dividend 9/15/2017 8:20:55 AM
Abbott (ABT) Release: FreeStyle Libre Flash Glucose Monitoring Technology Gains Reimbursement Approval From The United Kingdom's National Health Service 9/13/2017 8:00:38 AM
Abbott (ABT) Stops Global Sales of 1st-Gen Absorb Stents Due to Low Sales 9/11/2017 7:17:34 AM
Carmat (ALCAR.PA) Appoints Francesco Arecchi, Previously Product Manager EMEA Structural Heart At Abbott (ABT), As Marketing Manager 9/1/2017 8:00:38 AM
Abbott (ABT) Announces Extension Of Cash Tender Offer For All Outstanding Shares Of Series B Convertible Perpetual Preferred Stock Of Alere (ALR) 9/1/2017 6:24:42 AM
Abbott (ABT) Release: Revolutionary Glucose Monitoring Technology FreeStyle Libre Now Reimbursed Across Japan 8/31/2017 11:22:53 AM